Okay, and Wow, Ohm. So the short version is: Le
Post# of 148280
(Total Views: 399)
Posted On: 09/02/2021 4:21:07 PM
Okay, and Wow, Ohm.
So the short version is: Leron occupies and therefore blockades CCR5. This downregulates Interleukin-13, which increases a1-antitrypsin and thus protects mitochondria.
And mitochondria malfunction is linked to a host of bad syndromes or diseases, because it helps the body break down fat (like hepatic fat, in NASH), eliminate nitrogen (an imbalance leads to ME/Chronic Fatigue), and protects the health of neurons. And mitochondrial imbalance is also responsible for small matters like "cancer, diabetes, inflammatory diseases, hypertension, neurodegenerative and ischemia-related diseases, as well as aging."
I said Wow before, so I am legally enjoined from saying it again. Those little mitochondria dudes deserve respect. So Ohm, could this be the MOA key to why Leron might be effective against many of the diseases on your list?
By the way: thanks.
So the short version is: Leron occupies and therefore blockades CCR5. This downregulates Interleukin-13, which increases a1-antitrypsin and thus protects mitochondria.
And mitochondria malfunction is linked to a host of bad syndromes or diseases, because it helps the body break down fat (like hepatic fat, in NASH), eliminate nitrogen (an imbalance leads to ME/Chronic Fatigue), and protects the health of neurons. And mitochondrial imbalance is also responsible for small matters like "cancer, diabetes, inflammatory diseases, hypertension, neurodegenerative and ischemia-related diseases, as well as aging."
I said Wow before, so I am legally enjoined from saying it again. Those little mitochondria dudes deserve respect. So Ohm, could this be the MOA key to why Leron might be effective against many of the diseases on your list?
By the way: thanks.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼